CAV1 and malignant colon neoplasm: To evaluate whether CAV1 expression is associated with these processes, HT29(US) colon cancer cells were treated with a general NOS inhibitor, Nω-Nitro-L-arginine methyl ester hydrochloride (L-NAME) (Figure 4A).